CH489516A - Verfahren zur Herstellung von neuen Oxazolidinderivaten - Google Patents

Verfahren zur Herstellung von neuen Oxazolidinderivaten

Info

Publication number
CH489516A
CH489516A CH1432169A CH1432169A CH489516A CH 489516 A CH489516 A CH 489516A CH 1432169 A CH1432169 A CH 1432169A CH 1432169 A CH1432169 A CH 1432169A CH 489516 A CH489516 A CH 489516A
Authority
CH
Switzerland
Prior art keywords
preparation
oxazolidine derivatives
new
new oxazolidine
derivatives
Prior art date
Application number
CH1432169A
Other languages
English (en)
Inventor
Max Dr Wilhelm
Karl Dr Schenker
Paul Dr Schmidt
Ulrich Dr Daeniker Hans
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Priority to CH1432169A priority Critical patent/CH489516A/de
Priority claimed from CH962965A external-priority patent/CH484172A/de
Priority to CH1585465A priority patent/CH500216A/de
Publication of CH489516A publication Critical patent/CH489516A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1432169A 1965-07-09 1965-07-09 Verfahren zur Herstellung von neuen Oxazolidinderivaten CH489516A (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CH1432169A CH489516A (de) 1965-07-09 1965-07-09 Verfahren zur Herstellung von neuen Oxazolidinderivaten
CH1585465A CH500216A (de) 1965-07-09 1965-11-17 Verfahren zur Herstellung von neuen Oxazolidinderivaten

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
CH962965A CH484172A (de) 1965-07-09 1965-07-09 Verfahren zur Herstellung eines neuen Oxazolidinons
CH1432269A CH490405A (de) 1965-07-09 1965-07-09 Verfahren zur Herstellung von neuen Oxazolidinderivaten
CH1432169A CH489516A (de) 1965-07-09 1965-07-09 Verfahren zur Herstellung von neuen Oxazolidinderivaten
CH1585465A CH500216A (de) 1965-07-09 1965-11-17 Verfahren zur Herstellung von neuen Oxazolidinderivaten
CH1585565A CH512504A (de) 1965-07-09 1965-11-17 Verfahren zur Herstellung von neuen Oxazolidin-2-on-verbindungen
CH505966A CH507271A (de) 1965-07-09 1966-04-06 Verfahren zur Herstellung von neuen Oxazolidin-2-thion-Verbindungen
CH667066 1966-05-06

Publications (1)

Publication Number Publication Date
CH489516A true CH489516A (de) 1970-04-30

Family

ID=27561100

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1432169A CH489516A (de) 1965-07-09 1965-07-09 Verfahren zur Herstellung von neuen Oxazolidinderivaten
CH1585465A CH500216A (de) 1965-07-09 1965-11-17 Verfahren zur Herstellung von neuen Oxazolidinderivaten

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH1585465A CH500216A (de) 1965-07-09 1965-11-17 Verfahren zur Herstellung von neuen Oxazolidinderivaten

Country Status (1)

Country Link
CH (2) CH489516A (de)

Also Published As

Publication number Publication date
CH500216A (de) 1970-12-15

Similar Documents

Publication Publication Date Title
CH451200A (de) Verfahren zur Herstellung von neuen Bis-alkanolaminderivaten
AT281021B (de) Verfahren zur herstellung von neuen oxazolidinonderivaten
CH493468A (de) Verfahren zur Herstellung von neuen 2-Amido-halogen-benzylaminen
CH451201A (de) Verfahren zur Herstellung von neuen Phenylalkanolaminderivaten
CH451139A (de) Verfahren zur Herstellung von neuen Indenopyridin-Derivaten
CH458365A (de) Verfahren zur Herstellung von neuen Picolylamin-Derivaten
CH490405A (de) Verfahren zur Herstellung von neuen Oxazolidinderivaten
CH471124A (de) Verfahren zur Herstellung von neuen Cyclohexanderivaten
CH476735A (de) Verfahren zur Herstellung von neuen 2-Mercaptoimidazolderivaten
CH469656A (de) Verfahren zur Herstellung von neuen 2-Amino-benzylaminen
AT240376B (de) Verfahren zur Herstellung von neuen 4-Aza-thioxanthen-Derivaten
CH459206A (de) Verfahren zur Herstellung von neuen 7-Amino-carbostyrilen
CH475270A (de) Verfahren zur Herstellung von neuen 5-Nitro-furyl-derivaten
CH449626A (de) Verfahren zur Herstellung von neuen Isoxazolderivaten
AT267519B (de) Verfahren zur Herstellung von neuen Benzimidazolderivaten
CH471146A (de) Verfahren zur Herstellung von neuen Morpholinderivaten
AT255412B (de) Verfahren zur Herstellung von neuen 3-Nitro-2-oxo-tetrahydroimidazolderivaten
AT261634B (de) Verfahren zur Herstellung von neuen Phosphoramidothioaten
CH516506A (de) Verfahren zur Herstellung von neuen N-Phenylisopropylalkylaminen
AT258304B (de) Verfahren zur Herstellung von neuen 2-Azetidinonderivaten
CH451141A (de) Verfahren zur Herstellung von neuen 1-Hydroxy-piperidinderivaten
AT263769B (de) Verfahren zur Herstellung von neuen Thiazolidinderivaten
AT265301B (de) Verfahren zur Herstellung von neuen 3-Morpholinon- oder 3-Morpholinthionderivaten
AT246131B (de) Verfahren zur Herstellung von neuen 5-Hydrazino-pyrazol-Derivaten
AT268270B (de) Verfahren zur Herstellung von neuen Benzimidazolderivaten

Legal Events

Date Code Title Description
PL Patent ceased